Transcriptomics

Dataset Information

0

Rapamycin treated CEM-C1 cells 3 hours


ABSTRACT: Drug resistance remains a major obstacle to successful cancer treatment. Here we use a novel approach to identify rapamycin as a glucocorticoid resistance reversal agent. A database of drug-associated gene expression profiles was screened for molecules whose profile overlapped with a gene expression signature of glucocorticoid (GC) sensitivity/resistance in Acute Lymphoblastic Leukemia (ALL) cells. The screen indicated the mTOR inhibitor rapamycin profile matched the signature of GC-sensitivity. We thus tested the hypothesis that rapamycin would induce GC sensitivity in lymphoid malignancy cells, and found that it sensitized cells to glucocorticoid induced apoptosis via modulation of antiapoptotic MCL1. These data indicate that MCL1 is an important regulator of GC-induced apoptosis, and that the combination of rapamycin and glucocorticoids has potential utility in ALL. Furthermore this approach represents a novel strategy for identification of promising combination therapies for cancer. Keywords: drug treatment

ORGANISM(S): Homo sapiens

PROVIDER: GSE5822 | GEO | 2006/09/14

SECONDARY ACCESSION(S): PRJNA104387

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2008-06-14 | E-GEOD-5822 | biostudies-arrayexpress
2008-06-14 | E-GEOD-5821 | biostudies-arrayexpress
2008-11-06 | E-GEOD-5824 | biostudies-arrayexpress
2009-04-04 | E-GEOD-5820 | biostudies-arrayexpress
2006-09-14 | GSE5820 | GEO
2006-09-14 | GSE5821 | GEO
2006-09-14 | GSE5824 | GEO
2011-03-22 | E-GEOD-27989 | biostudies-arrayexpress
2011-03-22 | GSE27989 | GEO
2017-08-30 | E-MTAB-4761 | biostudies-arrayexpress